The Legal and Moral Issues of Drugging Children
Jim Gottstein’s presentation March 29, 2012 at the APA’s Humanistic Division. Mr. Gottstein talks about the the legal and moral issues of the massive number...
Study of Antidepressants and Suicide is Retracted
A controversial 2010 paper, "Antidepressant Medication Prevents Suicide in Depression", has been retracted by Acta Psychiatrica Scandinavica. In a contemporaneous issue of British Journal of...
Illinois Rep. Calls for Task Force to Investigate “False Epidemics” and Psychotropic Drugs
Rep. Mary Flowers (D-Chicago) has introduced a resolution to the Illinois House of Representatives calling for a 'Task Force on Mental Diagnosis and Illinois...
Antidepressants and Advertising: Psychopharmaceuticals in Crisis
An article by written by faculty of the Harvard History of Science Department and the Program in Placebo Studies explores how "drug marketing portrays...
Psychiatrist Census is Declining
The declining number of U.S. medical students choosing psychiatry as a specialty will exacerbate what the A.P.A. already calls a shortage of psychiatrists, according...
FDA Adds Warnings to Celexa’s Label
Following up on last August's warning that high doses of Celexa can cause potentially fatal heart rhythm abnormalities, the FDA has added clarification to...
J&J Tries, Fails to Squeeze Whistle Blower in Texas Risperdal Case
In giving final approval to the $158 million settlement with Texas over illegal promotion of Risperdal, Judge John Dietz denied Johnson &Johnson's request to...
Arkansas Alleges Risperdal Causes Deaths in the Elderly and Lactation in Young Boys
In opening statements in its lawsuit against Johnson & Johnson for lying about Risperdal's risks and promoting its use for unapproved treatments, Arkansas' lawyer...
AztraZeneca Struggling as Generic Seroquel Gets the Green Light
With a U.S. judge refusing to grant an injunction against generic versions of it's top-selling drug Seroquel last Friday, the Wall Street Journal reports...
Psychiatric Drugs, Especially Antipsychotics, Contribute to Increasing Drug Costs
Antipsychotics have overtaken antidepressants as the most costly class of psychiatric medication in England, according to a study by Stephen Ilyas and Joanna Moncrieff...
Arkansas’ $1.25 Billion Risperdal Trial Starts Today
Arkansas' lawsuit against Johnson & Johnson for false and misleading claims regarding Risperdal is set to begin today, the fourth time J&J has a...
Pharmas Exiting Antidepressant Market
As patents expire on current antidepressants pharmaceutical companies are getting out of the market, according to an article in yesterday's Vancouver Sun. In the latest...
Recovery-Oriented Services Benefit Providers As Well
In a study of 114 case managers in Ohio, researchers from Bowling Green State University found that those working at a recovery-oriented center reported...
Pharmaceutical Trial Database Mysteriously Disappears
The Public Library of Science (PLoS) revealed today that the lead author of a study identifying publication bias (released this week in PLoS Medicine) has...
Publication Bias in Antipsychotic Trials
Researchers in Oregon looked for discrepancies between published and unpublished FDA-registered trials. They found that four of the 24 FDA-registered trials of second-generation antipsychotics identified...
International Society Removes “Schizophrenia” From Its Name
Calling "schizophrenia" an unscientific and stigmatizing construct - with little or no reliability or validity - that implies people with the diagnosis have an irreversible brain...
High Cost to Medicaid Programs For Off-Label Use of Antipsychotics
A study of 42 state Medicaid programs found that 58% of prescriptions for antipsychotics were not for schizophrenia or bipolar disorder. Off-label prescribing was most prevalent...
Rampant Prescription Errors in CA Nursing Homes
Recent investigations by the California Department of Public Health found that in 18 of 31 nursing homes in San Francisco (plus one outside of...
Mother Sues Pfizer for Alleged Zoloft-Related Birth Defects
The latest in a series of Zoloft-related birth defect lawsuits was filed in St. Louis yesterday, by a firm that claims to represent hundreds...
Millionaire Psychiatrist Accused of Deliberate Misdiagnosis for Gain
Multimillionaire U.K. psychiatrist Dr. George Hibbert is being investigated - potentially by Parliament - for deliberately misdiagnosing hundreds of parents with 'personality disorders' in order to...
Brain Science Doesn’t Explain All
In an essay in the Sydney Morning Herald, a psychiatrist explores how the same blind faith in reductionist economic models that lead to a global...
Vermont Moves to Community Care After Hurricane Destroys State Hospital
Vermont Governor Peter Shumlin "is going to use this tragedy of losing our State Hospital during (hurricane) Irene as an opportunity to deliver the...
Diagnosing Conflict-of-Interest Disorder
Article by Lisa Cosgrove from June, 2010 reviewing conflicts of interest related to the DSM.
Article → ...
Effort to Curb Antipsychotics for Dementia Announced
The Centers for Medicare and Medicaid Services is launching an initiative to curb the use of antipsychotic medications for nursing home residents with dementia....
Staff Behaviors Precede Violence and Aggression Among In-Patients
A review of articles and reports pertaining to violence and aggression in in-patient settings finds that limiting patients' freedoms is the most frequent antecedent...
